Improved RP-HPLC method for determination of bovine lactoferrin and its proteolytic degradation in simulated gastrointestinal fluids

Biomedical Chromatography

Volumn 27, Issue 2, 2013, Pages 197-202

  Yao, Xudong ^a   Bunt, Craig ^b   Cornish, Jillian ^c   Quek, Siew Young ^d   Wen, Jingyuan ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b LINCOLN UNIVERSITY   (New Zealand)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Bovine lactoferrin (bLf); Proteolysis; Pseudo first order kinetics; RP HPLC

Indexed keywords

MAMMALS;

BOVINE LACTOFERRIN; CORRELATION COEFFICIENT; GASTROINTESTINAL; HALF LIVES; PROTEOLYTIC DEGRADATION; PSEUDO FIRST-ORDER KINETICS; PSEUDO-FIRST ORDER KINETICS; RP-HPLC; RP-HPLC METHOD;

PROTEOLYSIS;

CHYMOTRYPSIN; LACTOFERRIN; PEPSIN A; PEPTIDE FRAGMENT; TRYPSIN;

ARTICLE; DERIVATIZATION; INTESTINE FLUID; LIMIT OF DETECTION; LIMIT OF QUANTITATION; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN STABILITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STOMACH JUICE;

BOVINAE;

EID: 84872002554     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.2771     Document Type: Article

References (30)

1. Aguilar MI. HPLC of peptides and proteins. In HPLC of Peptides and Proteins Methods and Protocols, Aguilar MI (ed.). Humana Press: Totawa, NJ, 2004; 3-8.
2. Baker EN. Lactoferrin: a multi-tasking protein par excellence. Cellular and Molecular Life Sciences 2005; 62(22): 2529-2530.
3. Bernkop-Schnurch A and Schmitz T. Presystemic metabolism of orally administered peptide drugs and strategies to overcome it. Current Drug Metabolism 2007; 8: 509-517.
4. Boyes B and Alpert A. Biochemical samples: proteins, nucleic acids, and carbohydrates, and related compounds. In Practical HPLC Method Development, 2nd edn, Snyder LR, Kirkland JJ and Glajch JL (eds). John Wiley & Sons: New York, 1997; 479-536.
5. Busquets MA, Alsina MA and Haro I. Peptides and liposomes: from biophysical to immunogenic studies. Current Drug Targets 2003; 4: 633-642.
6. Cornish J, Palmano K, Callon KE, Watson M, Lin JM, Valenti P, Naot D, Grey AB and Reid IR. Lactoferrin and bone: structure-activity relationships. Biochemistry and Cell Biology 2006; 84: 297-302.
7. Drackova M, Borkovcova I, Janstova B, Naiserova M, Pridalova H, Navratilova P and Vorlova L. Determination of lactoferrin in goat milk by HPLC method. Czech Journal of Food Sciences 2009; 27: 102-104.
8. Emami J, Hamishehkar H, Najafabad AR, Gilani K, Minaiyan M, Mahdavi H and Nokhodchi A. A novel approach to prepare insulin-loaded poly (lactic-co-glycolic acid) microcapsules and the protein stability study. Journal of Pharmaceutical Sciences 2009; 98: 1712-1731.
9. García-Fuentes M, Prego C, Torres D and Alonso MJ. A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly (ethyleneglycol) as carriers for oral calcitonin delivery. European Journal of Biochemistry 2005; 25: 133-143.
10. Hayashida K, Kaneko T, Takeuchi T, Shimizu H, Ando K and Harada E. Oral administration of lactoferrin inhibits inflammation and nociception in rat adjuvant-induced arthritis. The Journal of Veterinary Medical Science 2004; 66: 149-154.
11. Hoek KS, Milne JM, Grieve PA, Dionysius DA and Smith R. Antibacterial activity of bovine lactoferrin-derived peptides. Antimicrobial Agents and Chemotherapy 1997; 41(1): 54-59.
12. Hojrup P. Proteolytic peptide mapping. In HPLC of Peptides and Proteins Methods and Protocols, Aguilar MI (ed.). Humana Press: Totawa, NJ, 2004; 227-244.
13. Krol J, Litwinczuk Z, Brodziak A and Barlowska J. Lactoferrin, lysozyme and immunoglobulin G content in milk of four breeds of cows managed under intensive production system. Polish Journal of Veterinary Sciences 2010; 13(2): 357-361.
14. Metz-Boutique MH, Jolles J, Mazurier J, Schoentgen F, Legrand D, Spik G, Montreuil J and Jolles P. Human lactoferrin: amino acid sequence and structural comparisons with other transferrin. European Journal of Biochemistry 1984; 145: 659-676.
15. Murphy ME, Kariwa H, Mizutani T, Tanabe H, Yoshimatsu K, Arikawa J and Takashima I. Characterization of in vitro and in vivo antiviral activity of lactoferrin and ribavirin upon hantavirus. The Journal of Veterinary Medical Science 2001; 63: 637-645.
16. Roseanu A, Florian PE, Moisei M, Sima LE, Evans RW and Trif M. Liposomalization of lactoferrin enhanced its anti-tumoral effects on melanoma cells. Biometals 2010; 23: 485-492.
17. Sandomirsky BP, Galchenko SE and Galchenko KS. Antioxidative properties of lactoferrin from bovine colostrum before and after its lyophilization. CryoLetters 2003; 24: 275-280.
18. Sjostrom B and Bergenstahl B. Preparation of submicron drug particles in lecithin-stabilized o/w emulsions, I. Model studies of the precipitation of cholesteryl acetate. International Journal of Pharmaceutics 1992; 88: 53-62.
19. Szoka F and Papahadjopoulos D. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proceedings of the National Academy of Science of the United States of America 1978; 75: 4194-4198.
20. Takakura N, Wakabayashi H, Ishibashi H, Teraguchi S, Tamura Y, Yamaguchi H and Abe S. Oral lactoferrin treatment of experimental oral candidiasis in mice. Antimicrobial Agents and Chemotherapy 2003; 47: 2619-2623.
21. Tan ML, Choong PFM and Dass CR. Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery. Peptides 2010; 31: 184-193.
22. Tsuda H, Sekine K, Fujita K and Iigo M. Cancer prevention by bovine lactoferrin and underlying mechanisms - a review of experimental and clinical studies. Biochemistry and Cell Biology 2002; 80: 131-136.
23. Venkateswarlu V and Manjunath K. Preparation, characterization, and in vitro release kinetics of clozapine solid lipid nanopaticles. Journal of Controlled Release 2004; 95: 647-638.
24. Visser S, Slangen CJ and Rollema HS. Phentyping of bovine milk proteins by reversed-phase high performance liquid chromatography. Journal of Chromatography 1991; 548: 361-370.
25. Wedholm A, Hallen E, Larsen LB, Lindmark-Mansson H, Karlsson AH and Allmere T. Comparison of milk protein composition in a Swedish and a Danish dairy herd using reversed phase HPLC. Acta Agricultuae Scandinavica Section A 2006; 56: 8-15.
26. Wickner W. The assembly of protein in the biological membrane: the membrane trigger hypothesis. Annual Review of Biochemistry 1979; 48: 23-45.
27. Yamauchi K, Wakabayashi H, Hashimoto S, Teraguchi S, Hayasawa H and Tomita M. Effects of orally administered bovine lactoferrin on the immune system of healthy volunteers. Advances in Experimental Medicine and Biology 1998; 443: 261-265.
28. Yoshise RE, Matsumoto M, Chiji H, Kuwata H, Shin K, Yamauchi K, Tamura Y, Tanaka T, Kumura H and Shimazaki K. Profiles of bovine lactoferrin in the gastrointestinal tracts of rats as observed by ELISA, Western blotting and SELDI-affinity MS. Milchwissenschaft - Milk Science International 2007; 62: 446-450.
29. Zhang N, Ping Q, Huang G, Xu W, Cheng Y and Han X. Lectin modified solid lipid nanoparticles as carriers for oral administration of insulin. International Journal of Pharmaceutics 2006; 327: 153-159.
30. Zhou L, Beuerman RW, Barathi A and Tan D. Analysis of rabbit tear proteins by high-pressure liquid chromatography/electrospray ionization mass spectrometry. Rapid Communications in Mass Spectrometry 2003; 17: 401-412.